These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 16224452

  • 1. Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June-July 2005.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2005 Oct 14; 54(40):1023-5. PubMed ID: 16224452
    [Abstract] [Full Text] [Related]

  • 2. Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June 2005-September 2006.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2006 Oct 20; 55(41):1120-4. PubMed ID: 17060898
    [Abstract] [Full Text] [Related]

  • 3. Use of meningococcal vaccines in the United States.
    Bilukha O, Messonnier N, Fischer M.
    Pediatr Infect Dis J; 2007 May 20; 26(5):371-6. PubMed ID: 17468644
    [Abstract] [Full Text] [Related]

  • 4. Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, October 2005-February 2006.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2006 Apr 07; 55(13):364-6. PubMed ID: 16601664
    [Abstract] [Full Text] [Related]

  • 5. Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 Sep 25; 58(37):1042-3. PubMed ID: 19779400
    [Abstract] [Full Text] [Related]

  • 6. Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents.
    Jackson LA, Baxter R, Reisinger K, Karsten A, Shah J, Bedell L, Dull PM, V59P13 Study Group.
    Clin Infect Dis; 2009 Jul 01; 49(1):e1-10. PubMed ID: 19476428
    [Abstract] [Full Text] [Related]

  • 7. Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents.
    Keyserling H, Papa T, Koranyi K, Ryall R, Bassily E, Bybel MJ, Sullivan K, Gilmet G, Reinhardt A.
    Arch Pediatr Adolesc Med; 2005 Oct 01; 159(10):907-13. PubMed ID: 16203934
    [Abstract] [Full Text] [Related]

  • 8. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meissner HC, Baker CJ, Messonnier NE, Centers for Disease Control and Prevention (CDC).
    MMWR Recomm Rep; 2013 Mar 22; 62(RR-2):1-28. PubMed ID: 23515099
    [Abstract] [Full Text] [Related]

  • 9. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Bilukha OO, Rosenstein N, National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC).
    MMWR Recomm Rep; 2005 May 27; 54(RR-7):1-21. PubMed ID: 15917737
    [Abstract] [Full Text] [Related]

  • 10. Syncope after vaccination--United States, January 2005-July 2007.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2008 May 02; 57(17):457-60. PubMed ID: 18451756
    [Abstract] [Full Text] [Related]

  • 11. Licensure of a meningococcal conjugate vaccine for children aged 2 through 10 years and updated booster dose guidance for adolescents and other persons at increased risk for meningococcal disease--Advisory Committee on Immunization Practices (ACIP), 2011.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2011 Aug 05; 60(30):1018-9. PubMed ID: 21814165
    [Abstract] [Full Text] [Related]

  • 12. Menactra: a meningococcal conjugate vaccine.
    Med Lett Drugs Ther; 2005 Apr 11; 47(1206):29-31. PubMed ID: 15821633
    [Abstract] [Full Text] [Related]

  • 13. Prevention and control of meningococcal disease: recommendations for use of meningococcal vaccines in pediatric patients.
    American Academy of Pediatrics Committee on Infectious Diseases.
    Pediatrics; 2005 Aug 11; 116(2):496-505. PubMed ID: 15995007
    [Abstract] [Full Text] [Related]

  • 14. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases.
    Pediatrics; 2006 Mar 11; 117(3):965-78. PubMed ID: 16382131
    [Abstract] [Full Text] [Related]

  • 15. Update on prevention of meningococcal disease: focus on tetravalent meningococcal conjugate vaccine.
    Mehlhorn AJ, Balcer HE, Sucher BJ.
    Ann Pharmacother; 2006 Apr 11; 40(4):666-73. PubMed ID: 16595570
    [Abstract] [Full Text] [Related]

  • 16. Report from the Advisory Committee on Immunization Practices (ACIP): decision not to recommend routine vaccination of all children aged 2-10 years with quadrivalent meningococcal conjugate vaccine (MCV4).
    Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2008 May 02; 57(17):462-5. PubMed ID: 18451758
    [Abstract] [Full Text] [Related]

  • 17. Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use - Advisory Committee on Immunization Practices (ACIP), 2010.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2010 Mar 12; 59(9):273. PubMed ID: 20224545
    [Abstract] [Full Text] [Related]

  • 18. Updated recommendations for use of meningococcal conjugate vaccines --- Advisory Committee on Immunization Practices (ACIP), 2010.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2011 Jan 28; 60(3):72-6. PubMed ID: 21270745
    [Abstract] [Full Text] [Related]

  • 19. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
    Ortega-Sanchez IR, Meltzer MI, Shepard C, Zell E, Messonnier ML, Bilukha O, Zhang X, Stephens DS, Messonnier NE, Active Bacterial Core Surveillance Team.
    Clin Infect Dis; 2008 Jan 01; 46(1):1-13. PubMed ID: 18171206
    [Abstract] [Full Text] [Related]

  • 20. Prevention of meningococcal disease.
    Kimmel SR.
    Am Fam Physician; 2005 Nov 15; 72(10):2049-56. PubMed ID: 16342836
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.